SnapShot: Multiple Myeloma

Esteban Braggio; K. Martin Kortüm; A. Keith Stewart

doi:10.1016/j.ccell.2015.10.014

SnapShot: Multiple Myeloma

Esteban Braggio, K. Martin Kortüm, A. Keith Stewart

Research output: Contribution to journal › Short survey › peer-review

18 Scopus citations

Abstract

Multiple myeloma (MM) is a plasma cell malignancy characterized by a heterogeneous clinical presentation. Genetic abnormalities are not only key events in the origin and progression of the disease but are also useful tools for prognosis, risk stratification, and therapeutic decision making. Although still incurable, a revolution in the treatment of MM is currently ongoing, leading to a significant improvement of clinical outcome and survival. To view this SnapShot, open or download the PDF.

Original language	English (US)
Pages (from-to)	678-678.e1
Journal	Cancer cell
Volume	28
Issue number	5
DOIs	https://doi.org/10.1016/j.ccell.2015.10.014
State	Published - Nov 9 2015

ASJC Scopus subject areas

Oncology
Cell Biology
Cancer Research

Access to Document

10.1016/j.ccell.2015.10.014

Cite this

@article{a6d6c3cfb5a8450b9683a322ef9a5fc1,

title = "SnapShot: Multiple Myeloma",

abstract = "Multiple myeloma (MM) is a plasma cell malignancy characterized by a heterogeneous clinical presentation. Genetic abnormalities are not only key events in the origin and progression of the disease but are also useful tools for prognosis, risk stratification, and therapeutic decision making. Although still incurable, a revolution in the treatment of MM is currently ongoing, leading to a significant improvement of clinical outcome and survival. To view this SnapShot, open or download the PDF.",

author = "Esteban Braggio and Kort{\"u}m, {K. Martin} and Stewart, {A. Keith}",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",

year = "2015",

month = nov,

day = "9",

doi = "10.1016/j.ccell.2015.10.014",

language = "English (US)",

volume = "28",

pages = "678--678.e1",

journal = "Cancer cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - SnapShot

T2 - Multiple Myeloma

AU - Braggio, Esteban

AU - Kortüm, K. Martin

AU - Stewart, A. Keith

PY - 2015/11/9

Y1 - 2015/11/9

N2 - Multiple myeloma (MM) is a plasma cell malignancy characterized by a heterogeneous clinical presentation. Genetic abnormalities are not only key events in the origin and progression of the disease but are also useful tools for prognosis, risk stratification, and therapeutic decision making. Although still incurable, a revolution in the treatment of MM is currently ongoing, leading to a significant improvement of clinical outcome and survival. To view this SnapShot, open or download the PDF.

AB - Multiple myeloma (MM) is a plasma cell malignancy characterized by a heterogeneous clinical presentation. Genetic abnormalities are not only key events in the origin and progression of the disease but are also useful tools for prognosis, risk stratification, and therapeutic decision making. Although still incurable, a revolution in the treatment of MM is currently ongoing, leading to a significant improvement of clinical outcome and survival. To view this SnapShot, open or download the PDF.

UR - http://www.scopus.com/inward/record.url?scp=84946559108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946559108&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2015.10.014

DO - 10.1016/j.ccell.2015.10.014

M3 - Short survey

C2 - 26555176

AN - SCOPUS:84946559108

SN - 1535-6108

VL - 28

SP - 678-678.e1

JO - Cancer cell

JF - Cancer cell

IS - 5

ER -

SnapShot: Multiple Myeloma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this